Cargando…
The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population
Background: In the United States (US), colorectal cancer (CRC) is the second leading cause of cancer-related deaths. With the majority of the US population covered by employer-based health plans, employers can play a critical role in increasing CRC screening adherence, which may help avert CRC-relat...
Autores principales: | Hathway, Joanne M, Miller-Wilson, Lesley-Ann, Sharma, Abhishek, Jensen, Ivar S, Yao, Weiyu, Raza, Sajjad, Parks, Philip D, Weinstein, Milton C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425769/ https://www.ncbi.nlm.nih.gov/pubmed/34512929 http://dx.doi.org/10.1080/20016689.2021.1948670 |
Ejemplares similares
-
Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening
por: Yang, Cuiping, et al.
Publicado: (2020) -
The cognitive adaptability and resiliency employment screener (CARES): tool development and testing
por: Torralba, Wilfredo Manuel R., et al.
Publicado: (2023) -
Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery
por: Ebner, Derek W., et al.
Publicado: (2023) -
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
por: Bosch, L.J.W., et al.
Publicado: (2019) -
High Positive Predictive Value of Multitarget Stool DNA After Aerodigestive Tract Radiotherapy
por: Ebner, Derek W., et al.
Publicado: (2022)